Loading…
Loading…
BTEC (Principal Healthcare Innovators ETF) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
See exactly how BTEC's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for BTEC and 80,000+ other tickers.
The fund typically allocates at least 80% of its overall assets, augmented by any borrowed capital used for investment, to equity holdings of companies within the healthcare industry. A considerable portion of its capital is directed towards innovative, early-stage businesses in areas such as medical equipment and supplies, pharmaceuticals, biotechnology, and the broader life sciences, many of which have not yet achieved consistent profitability.
Sometimes it feels like it's Nvidia's world and we all just live in it. Why bother with anything else?
As rising rates are in the cards, value stocks are likely to take a center stage in the near term.
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
If the ongoing pandemic has taught anything, it's the need for healthcare innovation. That's exactly what the Principal Healthcare Innovators ETF (BTEC) is all about.
In an effort to combat the coronavirus outbreak and accelerate the distribution process of extra doses in the United States, the FDA has approved the vaccine booster shots.